Tekla Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Tekla Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$110K	Hold	114,670	–	–	﹤0.01%	157
2023 Q1	$86K	Hold	114,670	–	–	﹤0.01%	171
2022 Q4	$42.3K	Hold	114,670	–	–	﹤0.01%	167
2022 Q3	$49K	Hold	114,670	–	–	﹤0.01%	162
2022 Q2	$89K	Hold	114,670	–	–	﹤0.01%	171
2022 Q1	$148K	Hold	114,670	–	–	0.01%	169
2021 Q4	$146K	Hold	114,670	–	–	﹤0.01%	165
2021 Q3	$250K	Hold	114,670	–	–	0.01%	167
2021 Q2	$430K	Hold	114,670	–	–	0.01%	183
2021 Q1	$374K	Hold	114,670	–	–	0.01%	190
2020 Q4	$391K	Hold	114,670	–	–	0.01%	193
2020 Q3	$468K	Hold	114,670	–	–	0.02%	196
2020 Q2	$388K	Hold	114,670	–	–	0.01%	211
2020 Q1	$267K	Hold	114,670	–	–	0.01%	204
2019 Q4	$417K	Hold	114,670	–	–	0.02%	198
2019 Q3	$951K	Hold	114,670	–	–	0.04%	160
2019 Q2	$987K	Hold	114,670	–	–	0.04%	163
2019 Q1	$1.23M	Hold	114,670	–	–	0.05%	149
2018 Q4	$1M	Hold	114,670	–	–	0.04%	165
2018 Q3	$1.93M	Buy	+114,670	New	+$2.48M	0.07%	159

Other funds holding SPPI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NYLIM

New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tekla Capital Management's SPPI Position: Q2 2023 in Review

Tekla Capital Management held its Spectrum Pharmaceuticals Inc (SPPI) position steady in Q2 2023 at 114,670 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #157.

Tekla Capital Management first reported a position in SPPI in Q3 2018 and has held it in 20 quarters since. The position peaked at $1.93M in Q3 2018. 78 funds tracked by Wall St. Rank hold SPPI as of Q2 2023.

Tekla Capital Management held 114,670 shares of Spectrum Pharmaceuticals Inc worth $110K as of Q2 2023.
Tekla Capital Management left its Spectrum Pharmaceuticals Inc share count unchanged in Q2 2023.
Spectrum Pharmaceuticals Inc made up ﹤0.01% of Tekla Capital Management's portfolio in Q2 2023, its #157 holding.
Tekla Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and has held it in 20 quarters since.
Tekla Capital Management's Spectrum Pharmaceuticals Inc position peaked at $1.93M in Q3 2018.
78 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.